Clinical Trials Browser

Phase 3 × OTHER × famitinib × Clear all

NCT06913777 2025-06-06

Neoadjuvant SNF Precision Therapy Phase III

Phase 3 Recruiting

Neoadjuvant Therapy

NCT05999149 2024-02-21

BCTOP-T-N01

Phase 3 Recruiting

Triple Negative Breast Neoplasms

NCT05760378 2024-02-06

Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.

Phase 3 Recruiting

Triple Negative Breast Neoplasms